Rhythm Biosciences (ASX: RHY): Interview with CEO David Atkins
Rhythm Biosciences (ASX:RHY) We spoke to Dr. David Atkins, CEO of Rhythm Biosciences (ASX: RHY), about…
AFT Pharmaceuticals (ASX:AFP) at the Pitt Street Research Life Sciences Conference 2024
AFT Pharmaceuticals (ASX:AFP) AFT Pharmaceuticals (ASX:AFP) CEO Dr. Harley Atkinson presented at the Pitt Street Research…
Island Pharmaceuticals (ASX:ILA) spoke at the Pitt Street Research Life Sciences Conference 2024
Island Pharmaceuticals (ASX:ILA) Island Pharmaceuticals (ASX:ILA) Executive Chairman Dr. Paul MacLeman spoke at the Pitt Street…
Cann Group (ASX:CAN) at the Pitt Street Research Life Sciences Conference 2024
Cann Group (ASX:CAN) Cann Group (ASX:CAN) Jenni Pilcher spoke at the Pitt Street Research Life Sciences…
Actinogen (ASX:ACW) presented at the Pitt Street Research Life Science Conference 2024
Actinogen (ASX:ACW) Dr. Steve Gourlay, MD & CEO of Actinogen (ASX:ACW), presented at the Pitt Street…
Graphite play Black Rock Mining (ASX:BKT) has got its ducks in a row in 2024
Black Rock Mining (ASX:BKT) We spoke with John de Vries, CEO of Black Rock Mining (ASX:…
Invion (ASX:IVX) at the Pitt Street Research Life Sciences Conference 2024
Invion (ASX:IVX) Thian Chew, Executive Chair and CEO of Invion (ASX:IVX), presented at the Pitt Street…
Percheron Therapeutics (ASX:PER) presented at the Pitt Street Research Life Sciences Conference 2024
Percheron Therapeutics (ASX:PER) Dr James Garner, MD & CEO of Percheron Therapeutics (ASX:PER), presented at the…
Proteomics International Laboratories (ASX:PIQ) presenting at the Pitt Street Research Life Sciences Conference 2024
Proteomics International Laboratories Proteomics International Laboratories‘ (ASX:PIQ) MD, Dr Richard Lipscombe, spoke at the Pitt Street…
Archer Materials (ASX:AXE) R&D is on track to deliver great things!
Archer Materials is tracking well with the development of the Biochip and 12CQ We spoke with…
Weebit Nano (ASX:WBT) is on track for more commercial deals in 2024
Weebit Nano (ASX:WBT) We spoke with Weebit Nano CEO, Coby Hanoch, about the A$1m in…
Actinogen Medical (ASX:ACW): Interview with CEO Dr Steve Gourlay
Actinogen Medical We talked with Dr Steve Gourlay, the CEO of Actinogen Medical (ASX:ACW), about the…
Chimeric Therapeutics (ASX:CHM): Solid prospects for licensing deals
Chimeric Therapeutics (ASX:CHM) We spoke to Dr Rebecca McQualter, Chief Operating Officer of Chimeric Therapeutics…
BrainChip (ASX:BRN): Post AGM interview with CEO Sean Hehir
Interview with Sean Hehir, CEO of BrainChip (ASX:BRN) We spoke with Sean Hehir, CEO of BrainChip…
GreenHy2 (ASX: H2G): Interview with Managing Director Dr. Paul Dalgleish, Managing Director
GreenHy2 (ASX: H2G) We spoke to Dr. Paul Dalgleish, CEO of GreenHy2 (ASX:H2G), about the company’s…
WhiteHawk (ASX:WHK): Many opportunities in Cyber Security for the taking
WhiteHawk (ASX:WHK) We spoke with Terry Roberts, CEO of Cyber Security company WhiteHawk (ASX:WHK), about the…
Transition Resources (Pre IPO): Interview with MD David Wilson
Transition Resources We spoke to David Wilson, Managing Director of the privately held Transition Resources, about…